DOI QR코드

DOI QR Code

Demineralized dentin matrix combined with recombinant human bone morphogenetic protein-2 in rabbit calvarial defects

  • Um, In-Woong (R&D Institute, Korea Tooth Bank) ;
  • Hwang, Suk-Hyun (Department of Medicine, Korea University Graduate School) ;
  • Kim, Young-Kyun (Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Kim, Moon-Young (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Jun, Sang-Ho (Department of Dentistry, Korea University Anam Hospital) ;
  • Ryu, Jae-Jun (Department of Dentistry, Korea University Anam Hospital) ;
  • Jang, Hyon-Seok (Department of Dentistry, Korea University Ansan Hospital)
  • 투고 : 2016.01.20
  • 심사 : 2016.03.13
  • 발행 : 2016.04.30

초록

Objectives: The aim of this study was to compare the osteogenic effects of demineralized dentin matrix (DDM) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2) in rabbit calvarial defects with DDM and anorganic bovine bone (ABB) combined with rhBMP-2. Materials and Methods: Four round defects with 8-mm diameters were created in each rabbit calvaria. Each defect was treated with one of the following: 1) DDM, 2) ABB/rhBMP-2, or 3) DDM/rhBMP-2. The rhBMP-2 was combined with DDM and ABB according to a stepwise dry and dip lyophilizing protocol. Histological and microcomputed tomography (${\mu}CT$) analyses were performed to measure the amount of bone formation and bone volume after 2- and 8-week healing intervals. Results: Upon histological observation at two weeks, the DDM and ABB/rhBMP-2 groups showed osteoconductive bone formation, while the DDM/rhBMP-2 group showed osteoconductive and osteoinductive bone formation. New bone formation was higher in DDM/rhBMP-2, DDM and ABB decreasing order. The amounts of bone formation were very similar at two weeks; however, at eight weeks, the DDM/rhBMP-2 group showed a twofold greater amount of bone formation compared to the DDM and ABB/rhBMP-2 groups. The ${\mu}CT$ analysis showed markedly increased bone volume in the DDM/rhBMP-2 group at eight weeks compared with that of the DDM group. Notably, there was a slight decrease in bone volume in the ABB/rhBMP-2 group at eight weeks. There were no significant differences among the DDM, ABB/rhBMP-2, and DDM/rhBMP-2 groups at two or eight weeks. Conclusion: Within the limitations of this study, DDM appears to be a suitable carrier for rhBMP-2 in orthotopic sites.

키워드

참고문헌

  1. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-34. https://doi.org/10.2106/00004623-200212000-00001
  2. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-Cage lumbar tapered fusion device. J Spinal Disord Tech 2003;16:113-22. https://doi.org/10.1097/00024720-200304000-00001
  3. Ripamonti U, Reddi AH. Periodontal regeneration: potential role of bone morphogenetic proteins. J Periodontal Res 1994;29:225-35. https://doi.org/10.1111/j.1600-0765.1994.tb01216.x
  4. Asahina I. Bone morphogenetic proteins: their history and characteristics. J Hard Tissue Biol 2014;23:283-6. https://doi.org/10.2485/jhtb.23.283
  5. Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G, Macroporous. Biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials 1998;19:133-9. https://doi.org/10.1016/S0142-9612(97)00180-4
  6. Kim CS, Kim JI, Kim J, Choi SH, Chai JK, Kim CK, et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005;26:2501-7. https://doi.org/10.1016/j.biomaterials.2004.07.015
  7. Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, et al. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-74. https://doi.org/10.1902/jop.2005.76.10.1667
  8. Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al. Pivotal randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009;67:1947-60. https://doi.org/10.1016/j.joms.2009.04.085
  9. Ike M, Urist MR. Recycled dentin root matrix for a carrier of recombinant human bone morphogenetic protein. J Oral Implantol 1998;24:124-32. https://doi.org/10.1563/1548-1336(1998)024<0124:RDRMFA>2.3.CO;2
  10. Murata M. Bone engineering using human demineralixed dentin matrix and recombinant human BMP-2. J Hard Tissue Biol 2005;14:80-1. https://doi.org/10.2485/jhtb.14.80
  11. Kim YK, Um IW, An HJ, Kim KW, Hong KS, Murata M. Effects of demineralized dentin matrix used as an rhBMP-2 carrier for bone regeneration. J Hard Tissue Biol 2014;23:415-22. https://doi.org/10.2485/jhtb.23.415
  12. Kim YK, Kwon KH, Lee ES, Kim CH, Kim MY, Um IW. Experimental study on human demineralized dentin matrix as rhBMP-2 carrier in vivo. J Dent App 2015;2:269-73.
  13. Jung JH, Yun JH, Um YJ, Jung UW, Kim CS, Choi SH, et al. Bone formation of Escherichia coli expressed rhBMP-2 on absorbable collagen block in rat calvarial defects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:298-305. https://doi.org/10.1016/j.tripleo.2010.05.011
  14. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003;55:1613-29. https://doi.org/10.1016/j.addr.2003.08.010
  15. Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005;76:605-13. https://doi.org/10.1902/jop.2005.76.4.605
  16. McKay WF, Peckham SM, Marotta JS. The science of rhBMP-2. St. Louis: Quality Medical Publishing; 2006.
  17. Schutzenberger S, Schultz A, Hausner T, Hopf R, Zanoni G, Morton T, et al. The optimal carrier for BMP-2: a comparison of collagen versus fibrin matrix. Arch Orthop Trauma Surg 2012;132:1363-70. https://doi.org/10.1007/s00402-012-1551-2
  18. Jung SY, KO YJ, Jang HS, Kang SW, Park JH. The effect of carrier for BMP-2 delivery on histological aspects of tissue-engineered bone. Tissue Eng Regen Med 2013;10:341-6. https://doi.org/10.1007/s13770-013-1102-0
  19. Schmitt C, Lutz R, Doering H, Lell M, Ratky J, Schlegel KA. Bio-Oss block combined with BMP-2 and VEGF for the regeneration of bony defects and vertical augmentation. Clin Oral Implants Res 2013;24:450-60. https://doi.org/10.1111/j.1600-0501.2011.02351.x
  20. Kim YK, Um IW, Murata M. Tooth bank system for bone regeneration: safety report. J Hard Tissue Biol 2014;23:371-6. https://doi.org/10.2485/jhtb.23.371
  21. Kim YK, Kim SG, Byeon JH, Lee HJ, UM IU, Lim SC, et al. Development of a novel bone grafting material using autogenous teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:496-503. https://doi.org/10.1016/j.tripleo.2009.10.017
  22. Murata M, Kawai T, Kawakami T, Akazawa T, Tazaki J, Ito K, et al. Human acid-insoluble dentin with BMP-2 accelerates bone induction in subcutaneous and intramuscular tissues. J Ceram Soc Jpn 2010;118:438-41. https://doi.org/10.2109/jcersj2.118.438

피인용 문헌

  1. Histological Comparison of Autogenous and Allogenic Demineralized Dentin Matrix Loaded with Recombinant Human Bone Morphogenetic Protein-2 for Alveolar Bone Repair: A Preliminary Report vol.26, pp.4, 2016, https://doi.org/10.2485/jhtb.26.417
  2. Evaluation of a Porous Hydroxyapatite Granule and Gelatin Hydrogel Microsphere Composite in Bone Regeneration vol.26, pp.2, 2017, https://doi.org/10.2485/jhtb.26.203
  3. Evaluation of bone healing using rhBMP-2 soaked hydroxyapatite in ridge augmentation: a prospective observational study vol.39, pp.39, 2017, https://doi.org/10.1186/s40902-017-0138-9
  4. Demineralized Dentin Matrix as a Carrier of Recombinant Human Bone Morphogenetic Proteins: in Vivo Study vol.27, pp.3, 2016, https://doi.org/10.2485/jhtb.27.219
  5. Volumetric, Radiographic, and Histologic Analyses of Demineralized Dentin Matrix Combined with Recombinant Human Bone Morphogenetic Protein-2 for Ridge Preservation: A Prospective Randomized Controlle vol.8, pp.8, 2016, https://doi.org/10.3390/app8081288
  6. Nano-Structured Demineralized Human Dentin Matrix to Enhance Bone and Dental Repair and Regeneration vol.9, pp.5, 2016, https://doi.org/10.3390/app9051013
  7. Evaluation of the Bone Regeneration Effect of Recombinant Human Bone Morphogenic Protein-2 on Subperiosteal Bone Graft in the Rat Calvarial Model vol.12, pp.10, 2016, https://doi.org/10.3390/ma12101613
  8. Human Fresh Fibrin Membrane with Bone Morphogenetic Protein-2 (BMP-2) Induces Bone Formation in the Subcutaneous Tissues of Nude Mice vol.14, pp.1, 2016, https://doi.org/10.3390/ma14010150
  9. Comparison of Bone Regeneration in Different Forms of Bovine Bone Scaffolds with Recombinant Human Bone Morphogenetic Protein-2 vol.22, pp.20, 2021, https://doi.org/10.3390/ijms222011121
  10. Prognosis of single tooth implants following alveolar ridge preservation with two recombinant human bone morphogenetic protein-2 delivery systems vol.21, pp.1, 2016, https://doi.org/10.1186/s12903-021-01565-5